89 results
Page 4 of 5
424B3
00g952
6 Nov 19
Prospectus supplement
9:15am
S-4/A
8n046r1
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm
S-4
sur3yn g6ed5z5
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
S-4
EX-10.36
y4rxlu6jrz91wdi
3 Sep 19
Registration of securities issued in business combination transactions
12:00am
8-K
EX-99.1
fmtij3 dzq
9 Aug 19
Gemphire Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
8:16am
425
EX-99.1
vtd7j50b
9 Aug 19
Business combination disclosure
8:14am
8-K
EX-10.6
rqlqvu xi9
25 Jul 19
Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company
6:38am
425
EX-10.6
t56op0
25 Jul 19
Business combination disclosure
6:36am
8-K
EX-99.1
0q7ph8y4ht9ql9xp h4
15 Mar 19
Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2018 Financial Results
8:05am
8-K
EX-99.1
7c4ci yxdzl5n9mnb
8 Nov 18
Gemphire Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
4:07pm
8-K
EX-99.1
xu7lvp8453lprfbhsp
13 Aug 18
Gemphire Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
5:01pm
8-K
EX-10.1
q2eqi2q
6 Aug 18
Entry into a Material Definitive Agreement
4:01pm